Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD
Clinical trial NCT03312283 · COMPLETED
Trial details
- NCT number
- NCT03312283
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2019-04-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.